Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assay

Clinical and Vaccine Immunology

Volumn 15, Issue 9, 2008, Pages 1387-1390

  Steele, Jane ^a   Collins, Stuart ^a   Wen, Kaisheng ^a   Ryan, Gordon ^a   Constandinou Williams, Christothea ^a   Woodman, Ciaran B J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; NEUTRALIZING ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PSEUDOVIRION BASED NEUTRALIZING ANTIBODY ASSAY; RELIABILITY; REPORTER GENE; REPRODUCIBILITY; SEROCONVERSION; VIRUS INFECTION; VIRUS LIKE AGENT; VIRUS LIKE PARTICLE ENZYME LINKED IMMUNOSORBENT ASSAY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; NEUTRALIZATION TESTS; PAPILLOMAVIRUS INFECTIONS; REPRODUCIBILITY OF RESULTS; VIROSOMES;

EID: 51649129331     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00013-08     Document Type: Article

References (9)

1. Buck, C. B., D. V. Pastrana, D. R. Lowy, and J. T. Schiller. 2005. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 119:445-462.
2. Carter, J. J., L. A. Koutsky, J. P. Hughes, S. K. Lee, J. Kuypers, N. Kiviat, et al. 2000. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J. Infect. Dis. 181:911-919.
3. Collins, S., S. Mazloomzadeh, H. Winter, P. Blomfield, A. Bailey, L. S. Young, and C. B. J. Woodman. 2002. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. Br. J. Obstet. Gynecol. 109:96-98.
4. Fleury, M. J., A. Touze, S. de Sanjose, F. X. Bosch, J. Klaustermeiyer, and P. Coursaget. 2008. Detection of neutralizing antibodies against human papillomavirus type 31 after natural infection using an assay based on intracellular assembly of luciferase-expressing pseudovirions. Clin. Vaccine Immunol. 15:172-175.
5. Ho, G. Y., Y. Y. Studentsov, R. Bierman, and R. D. Burk. 2004. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol. Biomarkers Prev. 13:110-116.
6. Landis, J. R., and G. G. Koch. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174.
7. Pastrana, D. V., C. B. Buck, Y.-Y. Pang, C. D. Thompson, P. E. Castle, P. C. Fitzgerald, S. Kruger Kjaer, D. R. Lowy, and J. T. Schiller. 2004. Reactivity of human sera in a sensitive, high-throughput pseudovirus neutralization assay for HPV16 and HPV18. Virology 321:205-216.
8. Winer, R. L., S. K. Lee, J. P. Hughes, D. E. Adam, N. B. Kiviat, and L. A. Koutsky. 2003. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am. J. Epidemiol. 157:218-226.
9. Woodman, C. B. J., S. Collins, H. Winter, A. Bailey, J. Ellis, P. Prior, M. Yates, T. P. Rollason, and L. S. Young. 2001. Natural history of cervical human papillomavirus infection in young women: a longitudinal study. Lancet 357:1831-1836.